What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Surgery
Mark S. Link mainly focuses on Internal medicine, Cardiology, Sudden death, Cardiomyopathy and Hypertrophic cardiomyopathy.
The various areas that Mark S. Link examines in his Internal medicine study include Guideline and Surgery.
Mark S. Link performs multidisciplinary studies into Cardiology and Task force in his work.
His studies in Sudden death integrate themes in fields like Vt ablation, Acetylcholine, Ventricular fibrillation, Sudden cardiac death and Risk factor.
Mark S. Link combines subjects such as Cardiopulmonary resuscitation and Tachycardia with his study of Ventricular fibrillation.
His Sudden cardiac death research is multidisciplinary, incorporating elements of Disease and Intensive care medicine.
His most cited work include:
- Part 8: Adult Advanced Cardiovascular Life Support 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care (1364 citations)
- 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (1224 citations)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoraci (929 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Sudden death, Sudden cardiac death and Hypertrophic cardiomyopathy.
His research is interdisciplinary, bridging the disciplines of Surgery and Internal medicine.
His study in the field of Ventricular fibrillation, Commotio cordis, Implantable cardioverter-defibrillator and Heart failure is also linked to topics like In patient.
Much of his study explores Sudden death relationship to Arrhythmogenic right ventricular dysplasia.
His Sudden cardiac death research includes elements of Athletes and Intensive care medicine.
In his work, Cardiovascular care and Emergency medical services is strongly intertwined with Cardiopulmonary resuscitation, which is a subfield of Intensive care medicine.
He most often published in these fields:
- Internal medicine (69.60%)
- Cardiology (66.33%)
- Sudden death (22.86%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (69.60%)
- Cardiology (66.33%)
- Hypertrophic cardiomyopathy (19.60%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Atrial fibrillation and Sudden cardiac death.
His study in Cardiomyopathy, Commotio cordis, Risk stratification, Asymptomatic and Electrocardiography falls under the purview of Internal medicine.
His work on Ventricular fibrillation, Sudden death, Ventricular tachycardia and Implantable cardioverter-defibrillator as part of general Cardiology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His Hypertrophic cardiomyopathy study combines topics from a wide range of disciplines, such as Sinus rhythm, Cardiovascular mortality and Left ventricular hypertrophy.
His study on Atrial fibrillation also encompasses disciplines like
- Heart failure and related Intensive care medicine,
- Stroke which is related to area like Myocardial infarction,
- Syncope and Physical therapy most often made with reference to Guideline.
His Sudden cardiac death research is multidisciplinary, relying on both Genetic testing, Athletes, Long QT syndrome and Brugada syndrome.
Between 2015 and 2021, his most popular works were:
- 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society (294 citations)
- Arrhythmogenic right ventricular cardiomyopathy (284 citations)
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy (148 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cardiology
- Surgery
His primary scientific interests are in Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Atrial fibrillation and Guideline.
His work in the fields of Internal medicine, such as Sudden death, Sudden cardiac death, Ventricular tachycardia and Asymptomatic, intersects with other areas such as In patient.
His work on Ventricular fibrillation, Cardiomyopathy and Heart disease as part of general Cardiology study is frequently linked to Reflex syncope, bridging the gap between disciplines.
Implantable defibrillator and Surgery is closely connected to Implantable cardioverter-defibrillator in his research, which is encompassed under the umbrella topic of Ventricular fibrillation.
Mark S. Link has researched Hypertrophic cardiomyopathy in several fields, including Heart failure, Natural history, Ventricular outflow tract, Ventricular Outflow Obstruction and Electrocardiography.
His Guideline study combines topics in areas such as Physical therapy, Syncope and Emergency medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
